超声作为肌少症有效且准确诊断工具的效用:慢性肾脏病中的性别特异性截断值
研究纳入113例慢性肾脏病患者,用B型二维超声测量股直肌横截面积,以生物电阻抗分析的骨骼肌质量指标为参考标准定义肌少症。股直肌横截面积对骨骼肌质量指数和总肌肉量仅为中等预测能力,男性截断值低于8.9 cm²、女性低于5.7 cm²,超声可能为慢性肾脏病患者肌少症诊断提供低成本简便方法。
要点
- 慢性肾脏病患者可用超声测量股直肌横截面积评估肌少症,男性截断值低于8.9 cm²。
- 女性股直肌横截面积截断值低于5.7 cm²基于骨骼肌质量指数/身高²,约登指数J=0.71。
- 股直肌横截面积对骨骼肌质量的预测能力仅为中等(R²=0.426–0.438)。
核心结论
- 超声可能为慢性肾脏病患者肌少症诊断提供低成本且简便的方法,有助于早期管理和及时干预以减轻该人群的影响。
研究设计与样本
- 研究纳入113例慢性肾脏病患者,平均年龄62.0岁(标准差14.1),男性占48%,估算肾小球滤过率38.0 mL/min/1.73m²(标准差21.5)。
- 采用B型二维超声成像获取股直肌横断面图像,以生物电阻抗分析测量的附肢骨骼肌质量和总肌肉量为基础,按既定标准定义肌少症水平肌肉量。
- 通过受试者工作特征曲线评估股直肌横截面积的判别能力,以最大约登指数确定最佳截断值。
诊断标准与关键数值
- 股直肌横截面积是附肢骨骼肌质量的中等预测因子(R²=0.426;P<.001),也是总肌肉量的中等预测因子(R²=0.438;P<.001)。
- 男性患者中,股直肌横截面积截断值低于8.9 cm²被认为适用于检测肌少症性肌肉量,最大约登指数J=0.47。
- 女性患者中,基于骨骼肌质量指数/身高²计算股直肌横截面积截断值低于5.7 cm²,约登指数J=0.71。
临床应用与阅片要点
- 在慢性肾脏病患者中可考虑用B型二维超声测量股直肌横截面积,按性别对应截断值(男性低于8.9 cm²、女性低于5.7 cm²)辅助识别肌少症性肌肉量。
- 阅片时应注意股直肌横截面积对骨骼肌质量的预测能力仅为中等,不能单独作为确诊依据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Patients with chronic kidney disease (CKD) have aberrant changes in body composition, including low skeletal muscle mass, a feature of "sarcopenia." The measurement of the (quadriceps) rectus femoris (RF) cross-sectional area (CSA) is widely used as a marker of muscle size. Cutoff values are needed to help discriminate the condition of an individual's muscle (eg, presence of sarcopenia) quickly and accurately. This could help distinguish those at greater risk and aid in targeted treatment programs.
METHODS: Transverse images of the RF were obtained by B-mode 2-dimensional ultrasound imaging. Sarcopenic levels of muscle mass were defined by established criteria (1, appendicular skeletal muscle mass [ASM]; 2, ASM/height2 ; and 3, ASM/body mass index) based on the ASM and total muscle mass measured by a bioelectrical impedance analysis. The discriminative power of RF-CSA was assessed by receiver operating characteristic curves, and optimal cutoffs were determined by the maximum Youden index (J).
RESULTS: One hundred thirteen patients with CKD (mean age [SD], 62.0 [14.1] years; 48% male; estimated glomerular filtration rate, 38.0 [21.5] mL/min/1.73m2 ) were included. The RF-CSA was a moderate predictor of ASM (R2 = 0.426; P < .001) and total muscle mass (R2 = 0.438; P < .001). With a maximum J of 0.47, in male patients, an RF-CSA cutoff of less than 8.9 cm2 was deemed an appropriate cutoff for detecting sarcopenic muscle mass. In female patients, an RF-CSA cutoff of less than 5.7 cm2 was calculated on the basis of ASM/height2 (J = 0.71).
CONCLUSIONS: Ultrasound may provide a low-cost and simple means to diagnose sarcopenia in patients with CKD. This would allow for early management and timely intervention to help mitigate the effects in this group.
引用
- Wilkinson TJ, Gore EF, Vadaszy N, et al. Utility of Ultrasound as a Valid and Accurate Diagnostic Tool for Sarcopenia: Sex-Specific Cutoff Values in Chronic Kidney Disease. J Ultrasound Med. 2020. PMID: 32780522. doi:10.1002/jum.15421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。